Uncoupling the Mitogenic and Metabolic Functions of FGF1 by Tuning FGF1-FGF Receptor Dimer Stability.
暂无分享,去创建一个
M. Mohammadi | Xiaokun Li | L. Cai | T. Neubert | L. Srinivasan | Yang Liu | Yi Tan | D. Conklin | Zhifeng Huang | Jingjing Deng | Yang Li | Lintao Song | Longwei Zhao | Qian Lin | Jianlou Niu | J. Gu
[1] M. Mohammadi,et al. Regulation of Receptor Binding Specificity of FGF9 by an Autoinhibitory Homodimerization. , 2017, Structure.
[2] Yi Xue,et al. Engineering a Therapeutic Lectin by Uncoupling Mitogenicity from Antiviral Activity , 2015, Cell.
[3] J. M. Suh,et al. Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer , 2014, Nature.
[4] M. Mohammadi,et al. Exploring mechanisms of FGF signalling through the lens of structural biology , 2013, Nature Reviews Molecular Cell Biology.
[5] J. M. Suh,et al. A PPARγ-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis , 2012, Nature.
[6] Masashi Suzuki,et al. Sulfated Glycosaminoglycans Are Required for Specific and Sensitive Fibroblast Growth Factor (FGF) 19 Signaling via FGF Receptor 4 and betaKlotho* , 2011, The Journal of Biological Chemistry.
[7] N. Itoh,et al. Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. , 2011, Journal of biochemistry.
[8] B. Lemon,et al. Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19) , 2010, Proceedings of the National Academy of Sciences.
[9] Richard A. Lang,et al. Differential Interactions of FGFs with Heparan Sulfate Control Gradient Formation and Branching Morphogenesis , 2009, Science Signaling.
[10] M. Hatakeyama,et al. Structural and Functional Basis of a Role for CRKL in a Fibroblast Growth Factor 8-Induced Feed-Forward Loop , 2009, Molecular and Cellular Biology.
[11] M. Mohammadi,et al. The FGF family: biology, pathophysiology and therapy , 2009, Nature Reviews Drug Discovery.
[12] J. Xu,et al. FGF21 N‐ and C‐termini play different roles in receptor interaction and activation , 2009, FEBS letters.
[13] Masashi Suzuki,et al. betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c. , 2008, Molecular endocrinology.
[14] S. Kliewer,et al. Tissue-specific Expression of βKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21* , 2007, Journal of Biological Chemistry.
[15] K. Rosenblatt,et al. βKlotho is required for metabolic activity of fibroblast growth factor 21 , 2007, Proceedings of the National Academy of Sciences.
[16] S. Kliewer,et al. Molecular Insights into the Klotho-Dependent, Endocrine Mode of Action of Fibroblast Growth Factor 19 Subfamily Members , 2007, Molecular and Cellular Biology.
[17] K. Okawa,et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23 , 2006, Nature.
[18] Shaun K Olsen,et al. Receptor Specificity of the Fibroblast Growth Factor Family , 2006, Journal of Biological Chemistry.
[19] T. Willson,et al. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Joyner,et al. Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. , 2006, Genes & development.
[21] J. Gromada,et al. FGF-21 as a novel metabolic regulator. , 2005, The Journal of clinical investigation.
[22] Shaun K Olsen,et al. Structural basis for fibroblast growth factor receptor activation. , 2005, Cytokine & growth factor reviews.
[23] V. P. Eswarakumar,et al. Cellular signaling by fibroblast growth factor receptors. , 2005, Cytokine & growth factor reviews.
[24] D. Ambrosetti,et al. Mechanisms underlying differential responses to FGF signaling. , 2005, Cytokine & growth factor reviews.
[25] Nobuyuki Itoh,et al. Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. , 2004, Human molecular genetics.
[26] Joseph Schlessinger,et al. SH2 and PTB Domains in Tyrosine Kinase Signaling , 2003, Science's STKE.
[27] M. Mohammadi,et al. Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[28] P. Rudland,et al. Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts. , 2002, The Biochemical journal.
[29] C. Kahn,et al. Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.
[30] A. Joyner,et al. Otx2, Gbx2 and Fgf8 interact to position and maintain a mid-hindbrain organizer. , 2000, Current opinion in cell biology.
[31] J. Schlessinger,et al. Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.
[32] J. Schlessinger,et al. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. , 2000, Molecular cell.
[33] Joseph Schlessinger,et al. Crystal Structures of Two FGF-FGFR Complexes Reveal the Determinants of Ligand-Receptor Specificity , 2000, Cell.
[34] H. Larsson,et al. Fibroblast Growth Factor Receptor-1-mediated Endothelial Cell Proliferation Is Dependent on the Src Homology (SH) 2/SH3 Domain-containing Adaptor Protein Crk* , 1999, The Journal of Biological Chemistry.
[35] D. Bar-Sagi,et al. A Lipid-Anchored Grb2-Binding Protein That Links FGF-Receptor Activation to the Ras/MAPK Signaling Pathway , 1997, Cell.
[36] C. MacArthur,et al. Receptor Specificity of the Fibroblast Growth Factor Family* , 1996, The Journal of Biological Chemistry.
[37] M. Jaye,et al. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction , 1996, Molecular and cellular biology.
[38] A. Rapak,et al. Stimulation of proliferation of a human osteosarcoma cell line by exogenous acidic fibroblast growth factor requires both activation of receptor tyrosine kinase and growth factor internalization , 1996, Molecular and cellular biology.
[39] Y. Li,et al. Cell transformation by fibroblast growth factors can be suppressed by truncated fibroblast growth factor receptors. , 1994, Molecular and cellular biology.
[40] E. Nabel,et al. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo , 1993, Nature.
[41] P. Månsson,et al. Heparin-binding growth factor type 1 (acidic fibroblast growth factor): a potential biphasic autocrine and paracrine regulator of hepatocyte regeneration. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[42] M. Mohammadi,et al. The structural biology of the FGF19 subfamily. , 2012, Advances in experimental medicine and biology.